Iovance Biotherapeutics (IOVA) Pops 43% on Stellar Q2. Here's What Comes Next
Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc. (IOVA)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 221,900 | $923,104 | +221800% | 0% | |
| 2. | 31,300 | $130,208 | +233% | 0% | |
| 3. | Walleye Capital Will England | 217 | $903 | -100% | 0% |
| 4. | Motley Fool Asset Management Bryan Hinmon | 0 | $0 | 0% | |
| 5. | NVerses Capital Jb Kim | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.84 | 30,000 | $55,200.00 | 30,000 | 2025-06-05 | Filing | |
| $1.74 | 5,600 | $9,743.44 | 206,852 | 2025-05-23 | Filing | |
| $1.69 | 25,000 | $42,250.00 | 374,646 | 2025-05-14 | Filing | |
| $9.15 | 250,000 | $2,287,500.00 | 320,150 | 2024-02-20 | Filing | |
| $9.15 | 32,000 | $292,800.00 | 54,000 | 2024-02-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.06 | 50,000 | $503,000.00 | 7,500 | 2024-11-12 | Filing | |
| $8.71 | 20,500 | $178,612.40 | 100,000 | 2016-08-25 | Filing | |
| $9.10 | 33,500 | $304,799.75 | 120,500 | 2016-08-24 | Filing | |
| $9.11 | 54,000 | $491,740.20 | 100,000 | 2016-08-22 | Filing | |
| $7.13 | 16,500 | $117,645.00 | 154,000 | 2015-09-08 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,162,097 | $4,834,325 | 0% | |
| 2. | 1,080,288 | $4,493,998 | 0.55% | |
| 3. | 882,132 | $3,669,669 | 0% | |
| 4. | 818,913 | $3,406,678 | 0.1% | |
| 5. | 380,000 | $1,599,800 | 0.02% |
News See All
12 Best Penny Stocks to Invest In According to Billionaires
The Russell 2000 Index, which represents small-cap companies, has gained 18.75% year to date.
10 Resilient Stocks Beating Market Slump
International Business Machines saw its share prices climb by 5.04 percent on Tuesday to close at $264.94 apiece, after JPMorgan turned bullish for its stock, thanks to the rosy prospects for its software...
10 Best Penny Stocks That Could Skyrocket in 2026
On June 4, Travis Prentice, CIO at The Informed Momentum Co., appeared on a CNBC Television interview to discuss what’s happening outside of the AI trade, particularly the small-cap stocks.
7 Hidden Penny Stocks to Invest In
Penny stocks continue to attract investors for good reason. Trading under $5, these stocks offer outsized returns and growth opportunities, particularly when backed by strong catalysts.
10 Hot Biotech Stocks Under $5 to Buy
On June 4, 2026, CNBC reported that global biopharma M&A is on track for its strongest year since the pre-pandemic peak seven years ago.
Investors' Stock Portfolio: Top 10 Penny Stocks To Buy
Risk appetite, driven by artificial intelligence fervor, continues to drive sentiment in US equity markets.
Iovance Biotherapeutics (IOVA) Gets Australia Nod for Amtagvi, Climbs 15%
Iovance Biotherapeutics climbed by 15.57 percent on Thursday to end at $4.38 apiece after securing the conditional approval of Australia’s Therapeutic Goods Administration (TGA) for the treatment of...
9 Stocks Crushing the Market With Surging Returns
Nine stocks posted strong gains on Thursday, bucking a mixed performance in the broader market, driven by positive company-specific developments that boosted buying appetite.
10 Most Shorted Mid-Cap and Small-Cap Stocks to Buy Now
Small cap and mid cap stocks have been on a roll in the first half of the year as investors rotate away from mega cap tech stocks.